We are live on ! Find out more
IMVT icon

Immunovant
IMVT

119 hedge funds and large institutions have $293M invested in Immunovant in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 41 increasing their positions, 40 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,278% more call options, than puts

Call options by funds: $47.9M | Put options by funds: $3.48M

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

8% more funds holding

Funds holding: 110 → 119 (+9)

3% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 40

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9.98% less ownership

Funds ownership: 39.35% → 29.38% (-10%)

28% less capital invested

Capital invested by funds: $407M → $293M (-$114M)

Holders
119
Holders Change
+9
Holders Change %
+8.18%
% of All Funds
2.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
41
Reduced
40
Closed
17
Calls
$47.9M
Puts
$3.48M
Net Calls
+$44.4M
Net Calls Change
-$3.18M

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
+$14.2M
2
EC
EcoR1 Capital
California
+$10.3M
3
AGM
Alpine Global Management
New York
+$9.02M
4
PIM
Platinum Investment Management
Australia
+$5.01M
5
FM
Frazier Management
Washington
+$2.99M

Top Sellers

1
WP
Woodline Partners
California
-$31.7M
2
BI
BVF Inc
California
-$13.5M
3
BC
Boxer Capital
California
-$10.6M
4
Invesco
Invesco
Georgia
-$7.59M
5
OFCM
One Fin Capital Management
California
-$6.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$43M +$14.2M +1,579,006 +47%
State Street
2
State Street
Massachusetts
$35.7M -$2.52M -278,843 -6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$32.6M -$2.27M -251,411 -6%
BlackRock
4
BlackRock
New York
$28.2M +$1.32M +146,214 +5%
AGM
5
Alpine Global Management
New York
$26.1M +$9.02M +1,000,200 +50%
Two Sigma Investments
6
Two Sigma Investments
New York
$9.94M -$1.18M -130,838 -10%
EC
7
EcoR1 Capital
California
$9.91M +$10.3M +1,140,819 New
Two Sigma Advisers
8
Two Sigma Advisers
New York
$8.76M +$1.66M +184,500 +22%
Morgan Stanley
9
Morgan Stanley
New York
$7.52M -$6.11M -677,126 -44%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$7.44M +$79.4K +8,798 +1%
FM
11
Frazier Management
Washington
$5.09M +$2.99M +331,759 +131%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
12
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.93M +$2.99M +331,400 +141%
PIM
13
Platinum Investment Management
Australia
$4.82M +$5.01M +555,065 New
MP
14
Mangrove Partners
Connecticut
$4.34M +$132K +14,632 +3%
Goldman Sachs
15
Goldman Sachs
New York
$3.99M +$2.28M +253,239 +123%
Northern Trust
16
Northern Trust
Illinois
$3.4M -$237K -26,265 -6%
Voloridge Investment Management
17
Voloridge Investment Management
Florida
$3.18M -$26.5K -2,936 -0.8%
N
18
Nuveen
North Carolina
$3.12M -$343K -38,075 -10%
JP Morgan Chase
19
JP Morgan Chase
New York
$3.12M +$2.96M +328,156 +1,071%
Citigroup
20
Citigroup
New York
$2.39M -$404K -44,829 -14%
Charles Schwab
21
Charles Schwab
California
$2.34M -$587K -65,058 -19%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$2.25M +$84.9K +9,412 +4%
American Century Companies
23
American Century Companies
Missouri
$2.18M +$1.01K +112 +0%
HF
24
HRT Financial
New York
$2.12M +$587K +65,037 +36%
WP
25
Woodline Partners
California
$2.1M -$31.7M -3,508,976 -94%
1
2 3 4 5

IMVT Hedge Fund Activity: Q3 2021 in Review

119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q3 2021, worth a combined $293M — down 28% from $407M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new IMVT positions and 17 closed out — a net gain of 9 holders — while 41 added to existing stakes and 40 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $14.2M. The largest seller was Woodline Partners, cutting an estimated $31.7M.

  • 119 institutional investors held Immunovant (IMVT) as of Q3 2021, up from 110 in Q2 2021.
  • Funds reported $293M of Immunovant stock for Q3 2021, down 28% quarter-over-quarter.
  • 26 funds opened new Immunovant positions in Q3 2021 and 17 closed out, a net change of +9 holders.
  • The largest Immunovant buyer in Q3 2021 was Eventide Asset Management, an estimated $14.2M added.
  • The largest Immunovant seller in Q3 2021 was Woodline Partners, an estimated $31.7M sold.

Based on aggregated 13F filings for Q3 2021.